Cargando…
The m(6)A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients
N(6)-methyladenosine (m(6)A) has an important epitranscriptomic modification that controls cancer self-renewal and cell fate. The addition of m(6)A to mRNA is a reversible modification. The deposition of m(6)A is encoded by a methyltransferase complex involving three homologous factors, jargonized a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256444/ https://www.ncbi.nlm.nih.gov/pubmed/32490170 http://dx.doi.org/10.1016/j.omto.2020.04.011 |